Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial

The most widely used regimens of graft-versus-host disease (GVHD) prophylaxis in HLA-matched unrelated donor peripheral blood stem cell transplantation (MUD-PBSCT) are based on anti-thymocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy). To improve the efficiency of GVHD prophylaxis, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zu, Yingling, Li, Zhen, Gui, Ruirui, Liu, Yanyan, Zhang, Yanli, Yu, Fengkuan, Zhao, Huifang, Fu, Yuewen, Zhan, Xinrong, Wang, Zhongliang, Xing, Pengtao, Wang, Xianjing, Wang, Huili, Zhou, Jian, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532243/
https://www.ncbi.nlm.nih.gov/pubmed/35840747
http://dx.doi.org/10.1038/s41409-022-01754-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532243/
https://www.ncbi.nlm.nih.gov/pubmed/35840747
http://dx.doi.org/10.1038/s41409-022-01754-y

Ejemplares similares